In vivo tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3 ε nanobody in breast cancer mice model

Immunotherapy,Volume 11, Issue 18, Page 1555-1567, December 2019.

Source: Immunotherapy - December 8, 2019 Category: Allergy & Immunology Authors: Azadeh Sharif Khatibi Nasim Hayati Roodbari Keivan Majidzade-A Parichehreh Yaghmaei Leila Farahmand Source Type: research